| Optometric Specialties Inc | |
|
3750 Santa Rosalia Dr Ste 102, Los Angeles, CA 90008-3685 | |
| (323) 294-7517 | |
| Not Available |
| Full Name | Optometric Specialties Inc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 3750 Santa Rosalia Dr Ste 102, Los Angeles, California |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023094570 | NPI | - | NPPES |
| GSD004160 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | COR 889 (California) | Primary |
| 332H00000X | Eyewear Supplier | COR 889 (California) | Secondary |
| Provider Name | Eric Gaylord |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1255317780 PECOS PAC ID: 2163487489 Enrollment ID: I20041129000747 |
News Archive
"A federal judge in Florida is not granting the federal government an extension of time to respond to a challenge to health care reform made by 20 states. U.S. District Judge Roger Vinson said there is no need for a delay, considering the federal government has already responded to Virginia Attorney General Ken Cuccinelli's challenge in a Virginia federal court. Seven states joined in an amended complaint filed May 14. The federal government has 33 days after that date to file a motion to dismiss the complaint, which it has done in Virginia" (O'Brien, 6/1).
For children with severe astigmatism, wearing glasses to correct blurred vision can significantly improve accurate reading speed, reports a study in the February issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.
The world's first ehealth app to support cancer patients and families has been launched.
OXiGENE, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today announced that the audit report from its independent registered public accounting firm on its financial statements for the fiscal year ended December 31, 2009, included in the Company's Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 16, 2010, contains an explanatory paragraph regarding the Company's ability to continue as a going concern.
The Drug Enforcement Administration, as part of its efforts to control the abuse and misuse of controlled substances and chemicals used in producing some over-the-counter drugs, maintains databases of individuals registered to handle these substances.
› Verified 5 days ago
| Provider Name | Ann I Gaylord |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1851561930 PECOS PAC ID: 4981765617 Enrollment ID: I20090721000410 |
News Archive
"A federal judge in Florida is not granting the federal government an extension of time to respond to a challenge to health care reform made by 20 states. U.S. District Judge Roger Vinson said there is no need for a delay, considering the federal government has already responded to Virginia Attorney General Ken Cuccinelli's challenge in a Virginia federal court. Seven states joined in an amended complaint filed May 14. The federal government has 33 days after that date to file a motion to dismiss the complaint, which it has done in Virginia" (O'Brien, 6/1).
For children with severe astigmatism, wearing glasses to correct blurred vision can significantly improve accurate reading speed, reports a study in the February issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.
The world's first ehealth app to support cancer patients and families has been launched.
OXiGENE, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today announced that the audit report from its independent registered public accounting firm on its financial statements for the fiscal year ended December 31, 2009, included in the Company's Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 16, 2010, contains an explanatory paragraph regarding the Company's ability to continue as a going concern.
The Drug Enforcement Administration, as part of its efforts to control the abuse and misuse of controlled substances and chemicals used in producing some over-the-counter drugs, maintains databases of individuals registered to handle these substances.
› Verified 5 days ago
| Provider Name | Natalie Imuetiyan Osayande |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1851941942 PECOS PAC ID: 7810329984 Enrollment ID: I20191111001438 |
News Archive
"A federal judge in Florida is not granting the federal government an extension of time to respond to a challenge to health care reform made by 20 states. U.S. District Judge Roger Vinson said there is no need for a delay, considering the federal government has already responded to Virginia Attorney General Ken Cuccinelli's challenge in a Virginia federal court. Seven states joined in an amended complaint filed May 14. The federal government has 33 days after that date to file a motion to dismiss the complaint, which it has done in Virginia" (O'Brien, 6/1).
For children with severe astigmatism, wearing glasses to correct blurred vision can significantly improve accurate reading speed, reports a study in the February issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.
The world's first ehealth app to support cancer patients and families has been launched.
OXiGENE, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today announced that the audit report from its independent registered public accounting firm on its financial statements for the fiscal year ended December 31, 2009, included in the Company's Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 16, 2010, contains an explanatory paragraph regarding the Company's ability to continue as a going concern.
The Drug Enforcement Administration, as part of its efforts to control the abuse and misuse of controlled substances and chemicals used in producing some over-the-counter drugs, maintains databases of individuals registered to handle these substances.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Optometric Specialties Inc 3750 Santa Rosalia Dr Ste 102, Los Angeles, CA 90008-3685 Ph: (323) 294-7517 | Optometric Specialties Inc 3750 Santa Rosalia Dr Ste 102, Los Angeles, CA 90008-3685 Ph: (323) 294-7517 |
News Archive
"A federal judge in Florida is not granting the federal government an extension of time to respond to a challenge to health care reform made by 20 states. U.S. District Judge Roger Vinson said there is no need for a delay, considering the federal government has already responded to Virginia Attorney General Ken Cuccinelli's challenge in a Virginia federal court. Seven states joined in an amended complaint filed May 14. The federal government has 33 days after that date to file a motion to dismiss the complaint, which it has done in Virginia" (O'Brien, 6/1).
For children with severe astigmatism, wearing glasses to correct blurred vision can significantly improve accurate reading speed, reports a study in the February issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.
The world's first ehealth app to support cancer patients and families has been launched.
OXiGENE, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today announced that the audit report from its independent registered public accounting firm on its financial statements for the fiscal year ended December 31, 2009, included in the Company's Annual Report on Form 10-K, filed with the Securities and Exchange Commission on March 16, 2010, contains an explanatory paragraph regarding the Company's ability to continue as a going concern.
The Drug Enforcement Administration, as part of its efforts to control the abuse and misuse of controlled substances and chemicals used in producing some over-the-counter drugs, maintains databases of individuals registered to handle these substances.
› Verified 5 days ago
Roxana Gilda De La Rosa, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 105 1/2 S Vermont Ave, Los Angeles, CA 90004 Phone: 213-383-8036 | |
Dr. Lernik Torossian, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 835 W Jefferson Blvd Unit 7-d, Los Angeles, CA 90089 Phone: 323-442-6335 | |
Optometric Eyesite Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 10939 West Pico Blvd, Los Angeles, CA 90064 Phone: 310-899-0077 | |
Vision To Learn Optometrist Medicare: Not Enrolled in Medicare Practice Location: 12100 Wilshire Blvd Ste 1275, Los Angeles, CA 90025 Phone: 800-485-9196 Fax: 213-402-5261 | |
Beverly Grove Vision Care Optometry, Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 511 S Fairfax Ave, Los Angeles, CA 90036 Phone: 323-879-9259 | |
Narda Sanchez, O.d., Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5500 W. Sunset Blvd, Los Angeles, CA 90028 Phone: 323-462-2816 | |
Michael Tay, OD Optometrist Medicare: Medicare Enrolled Practice Location: 4433 S Alameda St, Los Angeles, CA 90058 Phone: 323-988-1033 |